Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > I exercised a put today.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(751)
•••
Comment by Finallytherockon Apr 28, 2022 5:29pm
74 Views
Post# 34640396

RE:RE:RE:RE:RE:I exercised a put today.

RE:RE:RE:RE:RE:I exercised a put today.I am confident that jd is still reading my posts despite telling everyone he put me on ignore. he can't go on without knowing what i and others are posting. part of it is entertainment for this lonely, broke man. he has led many to the slaughterhouse with this stock and instead of admitting he has been terribly wrong after 10+ years, he continues to post that something big is going on behind closed doors. that is not fair to his lapdogs/sheep that read this and actually think something is happening. he is lying to them but they fail to see it. they continue to hold shares despite the stock going lower and lower and their losses getting bigger and biger. and i am the bad guy?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities